Literature DB >> 18436926

Fetal RHD typing: Is fetal RHD typing in all RhD negative women cost effective?

Ala Szczepura, Gouke Bonsel, Christian Krauth, Leeza Osipenko, Alexander Haverkamp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18436926      PMCID： PMC2335264          DOI： 10.1136/bmj.39556.499549.80

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.

Authors:  Jim Chilcott; Paul Tappenden; Myfanwy Lloyd Jones; Jeremy Wight; Katie Forman; Julie Wray; Catherine Beverley
Journal:  BJOG       Date:  2004-09       Impact factor: 6.531

2.  Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis.

Authors:  Ossie Geifman-Holtzman; Chad A Grotegut; John P Gaughan
Journal:  Am J Obstet Gynecol       Date:  2006-10       Impact factor: 8.661

Review 3.  SAFE--the Special Non-invasive Advances in Fetal and Neonatal Evaluation Network: aims and achievements.

Authors:  Lyn S Chitty; C Ellen van der Schoot; Sinuhe Hahn; Neil D Avent
Journal:  Prenat Diagn       Date:  2008-02       Impact factor: 3.050

4.  Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study.

Authors:  Kirstin Finning; Pete Martin; Joanna Summers; Edwin Massey; Geoff Poole; Geoff Daniels
Journal:  BMJ       Date:  2008-04-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.